Parallel Advisors’s PDL BioPharma, Inc. PDLI Stock Holding History

Parallel Advisors’s Portfolio PDLI Stock Details PDLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-681	Closed	–	–	3191
2021 Q1	$0	Hold	681	–	–	﹤0.01%	2988
2020 Q4	$2K	Hold	681	–	–	﹤0.01%	2383
2020 Q3	$2K	Buy	+681	New	+$2.17K	﹤0.01%	2392

Other funds holding PDLI

PWAM

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

Public Employees Retirement Association of Colorado Denver, Colorado $25.5B AUM 28.85% 1-Year Est. Return

Parallel Advisors's PDLI Position: Q2 2021 in Review

Parallel Advisors sold out of PDL BioPharma, Inc. (PDLI) in Q2 2021, closing a stake of 681 shares.

Parallel Advisors first reported a position in PDLI in Q3 2020 and held it in 3 quarters. The position peaked at $2K in Q4 2020. 8 funds tracked by Wall St. Rank hold PDLI as of Q2 2021.

Parallel Advisors reported no remaining PDL BioPharma, Inc. position as of Q2 2021 after selling out during the quarter.
Parallel Advisors sold 681 PDL BioPharma, Inc. shares in Q2 2021.
Parallel Advisors first reported a position in PDL BioPharma, Inc. in Q3 2020 and held it in 3 quarters.
Parallel Advisors's PDL BioPharma, Inc. position peaked at $2K in Q4 2020.
8 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q2 2021.

Based on Parallel Advisors's 13F filing for Q2 2021, filed 6 Aug 2021.